Paid Clinical Trials - 82,000 Members & Growing

  • Paid Clinical Trials
  • About Us
  • Auto-Updates
  • FAQ's
  • Quick Start Guide
www.GlobalTestMarket.com

 

Find Paid Clinical Trials Join Paid Clinical Trials ...

PaidClinicalTrials.org is a registry of compensated and uncompensated, federally and privately supported clinical trials conducted in the United States and around the world. Here you will find information about a trial's purpose, who may participate, locations, and phone numbers.

 

Find Paid Clinical Trials Clinical Trial Seekers - PCT is a public service, sponsor supported, clinical trial database that may be accessed by the general public at no charge in accordance with our terms of service use.

Clinical trials are added and removed each day on a 30 day rotation. For accuracy - We only list clinical trials that have been reported to these government agencies in the last 30 days:

 

U.S. National Library of Medicine,
U.S. Department of Health & Human Services
U.S. National Institutes of health Services.







Paid Clinical Trials - Auto Update Service

If you would like to receive timely and important notifications about new clinical trials in your area please fill out this short form. There is never any cost for our notification services. We value your privacy, your email address and member information is NEVER shared!

*  Your Email Address:
*  Preferred Format:
    Title:
    First Name:
    Country:
    State (US):
    City (UK):
    Territory (AU):

Tips for Finding Clinical Trials

 

One of the toughest and most-time consuming parts for medical research staff conducting the clinical trials is actually finding volunteers willing to participate. Research staff are looking for you! There are numerous ways to identify clinical trials looking for healthy human volunteers.

 

Trials are actively conducted by hospitals, universities, foundations, and contract research organizations (CROs, firms that conduct studies for big pharmaceutical and biotechnology companies). According to CISCRP, nearly 40% of these clinical trials can be learned about through media such as tv, radio, or printed ads. While finding studies through tv and radio ads might be difficult, you can actively scour the wanted section of your local newspapers to find trials.

Most local research clinics run ads for volunteers in the local newspaper, employment papers, on TV, and on the radio. They also post ads on Craigslist and on their own websites. Call them up as soon as you see something of interest. If the study is no longer recruiting volunteers, they might enter you in there database for future study participation.

 

Look up local research clinics in your phone book and ask (a) if they have any studies openly recruiting healthy volunteers and (b) if you could be entered into their volunteer database.

College campuses and major universities with research hospitals are also great places to find clinical trial. Schools of medicine, dentistry, and nursing, along with departments of psychology, sociology, and communications, at local universities, are always looking for willing volunteers for their experiments. Perform an internet search for the hospitals, schools, and departments on nearby campuses, then look for any section concerning clinical trials or research volunteers.


When searching for clinical trials on our website you will click on a Clinical Trial Information sheet like this example. Find Paid Clinical Trials Example Information Sheet. The first thing you should do is to see if the clinical trial is right for you. You can do this by quickly scanning the headings of the information sheet. These headings are highlighted on the left by blue icons as follows:


  >> Status of the Clinical Trial (This will appear at the top in red or green)


Purpose - This will briefly let you know about the clinical trial and how it is conducted.


Eligibility - This tells you age, gender and health status information. If you do not meet these eligibility requirement you should move to another clinical trial.


Contacts and Locations - This will list the locations the clinical trial is being conducted and it will usually list the contact person to call. Note - Even if your location is not listed you should call the clinical trial investigator. Sometimes their locations have not been updated or they are willing to pay time and travel expenses.


More Information - This will often give alternative contact people and other pertinent information about the trial.

These headings appear on the left side of the information sheet and are fairly self explanatory. Doing this will help you to quickly evaluate if the clinical trial is right for you.

 


 

Paid Clinical Trials Searching Tips

 

Paid Clinical Trials Check the Conditions Category - If you only search the "Locations" directory you are missing out on a lot of clinical trials. Trials that are listed by "Condition" usually have multiple locations and can add new locations as the study moves forward.

 

Paid Clinical Trials Register Your Profile with us. - You can post your location and condition in our personal clinical trials directory for FREE. This helps the research recruiters find you when the right trial becomes available. Register for Clinical Trials Here.

 

Paid Clinical Trials Call the Clinical Trial Recruiters - At the bottom of all the information sheets you will see a "Contact Information" heading. Many clinical trials can be conducted in remote locations and the recruiters can help you.

 

Paid Clinical Trials Subscribe to our Auto Update Service - By subscribing to our Auto Update Service you will receive automated emails informing you when new trials have opened in your area.

Sponsored Links







  • Conditions:   Neurofibromatosis;   Neurofibromatosis I;   Neurofibromatosis 2;   Schwannomatosis
    Intervention:   Behavioral: The Relaxation Response Resiliency Program (3RP) via Skype
    Sponsors:   Massachusetts General Hospital;   The Children's Tumor Foundation
    Recruiting - verified November 2014

  • Conditions:   Vestibular Schwannoma;   Meningioma;   Acoustic Neuroma;   Neurofibromatosis Type 2
    Intervention:   Drug: AR-42
    Sponsors:   Massachusetts Eye and Ear Infirmary;   Johns Hopkins University;   Mayo Clinic;   Stanford University;   Ohio State University;   Nationwide Children's Hospital
    Not yet recruiting - verified October 2014

  • Conditions:   Multiple Sclerosis;   Neuromyelitis Optica
    Intervention:   Biological: Tolerogenic Dendritic cells loaded with myelin peptides
    Sponsor:   Sara Varea
    Not yet recruiting - verified November 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: Ublituximab
    Sponsor:   Michael Levy
    Not yet recruiting - verified October 2014

  • Condition:   Vestibular Schwannoma
    Intervention:   Other: Preoperative vestibular rehabilitation
    Sponsors:   Central Hospital, Nancy, France;   University of Lorraine
    Not yet recruiting - verified October 2014

  • Condition:   Vestibular Schwannoma
    Intervention:   Radiation: gamma knife radiosurgery
    Sponsor:   Haukeland University Hospital
    Recruiting - verified October 2014

  • Condition:   Neurofibromatosis Type 2
    Intervention:   Device: MR imaging
    Sponsor:   Hayley Brooks
    Recruiting - verified September 2014

  • Conditions:   Amblyopia;   Anisometropia;   Strabismus
    Interventions:   Device: Dichoptic therapy;   Other: Patching therapy;   Device: Dioptic (non-dichoptic) therapy
    Sponsor:   University of California, San Francisco
    Not yet recruiting - verified September 2014

  • Condition:   Unilateral Vocal Cord Paralysis
    Intervention:  
    Sponsor:   Chang Gung Memorial Hospital
    Recruiting - verified February 2014

  • Conditions:   Devic's Syndrome;   Devic's Neuromyelitis Optica;   Devic Syndrome;   Devic's Disease;   Devic Disease
    Intervention:   Biological: Autologous mesenchymal stem cells
    Sponsor:   Tianjin Medical University General Hospital
    Recruiting - verified September 2014

  • Conditions:   Amblyopia;   Strabismus
    Intervention:   Device: Pinched Patch
    Sponsor:   Texas Children's Hospital
    Recruiting - verified September 2014

  • Conditions:   Stridor;   Vocal Cord Paralysis
    Intervention:  
    Sponsor:   Tel-Aviv Sourasky Medical Center
    Not yet recruiting - verified September 2014

  • Conditions:   Visual Acuity at Near;   Accuracy of Accommodation;   Prevention of Strabismus;   Task Readiness
    Interventions:   Device: bifocals;   Device: single vision glasses
    Sponsor:   Radboud University
    Not yet recruiting - verified September 2014

  • Conditions:   Frontotemporal Dementia;   Progressive Supranuclear Palsy;   Healthy Subjects
    Interventions:   Device: transcranial magnetic stimulation;   Other: MRI imaging;   Other: EEG recording;   Behavioral: Neuropsychological examination
    Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   Fondation pour la Recherche Médicale
    Not yet recruiting - verified May 2014

  • Condition:   Strabismus
    Intervention:   Device: strabismus video goggles
    Sponsors:   University of Zurich;   Albert Bruppacher-Stiftung;   Stiftung OPOS zugunsten von Wahrnehmungsbehinderten
    Not yet recruiting - verified August 2014

  • Condition:   Intermittent Exotropia
    Interventions:   Device: Overminus treatment;   Device: Non-overminus treatment
    Sponsors:   Jaeb Center for Health Research;   National Eye Institute (NEI)
    Not yet recruiting - verified August 2014

  • Condition:   Multiple Sclerosis
    Intervention:   Drug: MD1003 100mg capsule
    Sponsor:   Medday SAS
    Recruiting - verified August 2014

  • Conditions:   Progressive Supranuclear Palsy;   Multi-System Atrophy;   Parkinsonism
    Intervention:   Drug: [F18]-FDDNP
    Sponsor:   Fundacion Clinic per a la Recerca Biomédica
    Recruiting - verified July 2012

  • Condition:   Convergence Insufficiency
    Intervention:   Procedure: Office-based vergence/accommodative therapy
    Sponsors:   Salus University;   National Eye Institute (NEI);   Pennsylvania College of Optometry at Salus University;   Southern College of Optometry at Marshall B. Ketchum University;   Ohio State University College of Optometry;   University of Alabama, Birmingham, College of Optometry;   State University of New York College of Optometry;   Akron Children's Hospital;   NOVA College of Optometry;   Bascom Palmer
    Recruiting - verified August 2014

  • Condition:   Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD)
    Interventions:   Biological: MEDI-551;   Other: Placebo
    Sponsor:   MedImmune LLC
    Recruiting - verified November 2014

  • Conditions:   Acoustic Schwannoma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Meningioma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Tumor;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Meningeal Hemangiopericytoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Adult Supratentorial Primitive Neuroectodermal Tumor (PNET);   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Medulloepithelioma;   Childhood Supratentorial Ependymoma;   Meningeal Melanocytoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Cerebellar Astrocytoma;   Untreated Childhood Cerebral Astrocytoma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
    Interventions:   Radiation: gallium Ga 68-edotreotide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
    Sponsors:   University of Iowa;   National Cancer Institute (NCI);   Ride for Kids
    Recruiting - verified November 2014

  • Conditions:   Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
    Intervention:   Drug: Amifampridine Phosphate
    Sponsors:   Catalyst Pharmaceutical Partners, Inc;   Voisin Consulting Life Sciences, Inc.
    Available - verified July 2014

  • Conditions:   Oromandibular Dystonia;   Cranial Dystonia
    Intervention:   Drug: Levetiracetam
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified June 2014

  • Condition:   Leber Hereditary Optic Neuropathy
    Intervention:   Drug: cyclosporine
    Sponsor:   University Hospital, Angers
    Recruiting - verified January 2014

  • Conditions:   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Diffuse Astrocytoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Oligodendroglioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Cerebellar Astrocytoma;   Untreated Childhood Cerebral Astrocytoma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
    Interventions:   Drug: fluorine F 18 fluorodopa;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: magnetic resonance imaging
    Sponsors:   Stanford University;   National Cancer Institute (NCI)
    Not yet recruiting - verified November 2014

  • Condition:   Carotid Stenosis
    Interventions:   Procedure: Regional anesthesia;   Procedure: General anesthesia;   Device: Transcranial Doppler ultrasonography;   Procedure: blood gas analysis;   Procedure: invasive arterial blood pressure measurement;   Procedure: arterial blood gas measurement;   Behavioral: Neurological Control;   Behavioral: NIRS monitoring;   Device: oxygen supply (not invasive 'Vigileo')
    Sponsor:   Medical University Innsbruck
    Recruiting - verified August 2014

  • Conditions:   Mild Concussion;   Post Concussion Syndrome;   Vestibular Neuritis;   Dizziness;   Imbalance
    Intervention:  
    Sponsors:   Emory University;   U.S. Army Medical Research and Materiel Command;   National Football League;   General Electric;   UnderArmour
    Not yet recruiting - verified October 2014

  • Conditions:   Progressive Supranuclear Palsy;   Corticobasal Degeneration
    Interventions:   Drug: 18F-AV-1451;   Drug: florbetapir F18
    Sponsor:   Avid Radiopharmaceuticals
    Recruiting - verified September 2014

  • Conditions:   Transverse Myelitis;   Neuromyelitis Optica;   Idiopathic Transverse Myelitis;   Myelitis NOS
    Interventions:   Drug: Dalfampridine;   Drug: Placebo
    Sponsors:   Johns Hopkins University;   Acorda Therapeutics
    Recruiting - verified June 2014

  • Conditions:   Leber's Hereditary Optic Neuropathy;   G11778A Gene Mutation;   Human Mitochondrial ND4 Gene
    Interventions:   Drug: scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: scAAV2-P1ND4v2 1.0X10e11vg (High)
    Sponsors:   John Guy;   National Eye Institute (NEI)
    Recruiting - verified July 2014

  • Condition:   Chronic Progressive External Ophthalmoplegia
    Intervention:   Other: Magnetic Resonance Imaging
    Sponsor:   Rigshospitalet, Denmark
    Recruiting - verified June 2014

  • Conditions:   Glaucoma, Suspect;   Optic Nerve Hypoplasia and Abnormalities of the Central Nervous System;   Congenital Coloboma of the Optic Nerve;   Optic Nerve Head Pits, Bilateral Congenital
    Interventions:   Device: Cartoon video fixation target and cartoon character voice audio instructions during Humphrey perimetry;   Other: Usual Care procedures during Humphrey perimetry for children
    Sponsor:   Nova Southeastern University
    Not yet recruiting - verified June 2014

  • Condition:   Strabismus
    Interventions:   Drug: Injection of propofol 1.0mg/kg;   Drug: propofol 0.5mg/kg;   Drug: normal saline
    Sponsor:   Yonsei University
    Recruiting - verified July 2014

  • Conditions:   Primary Four Repeat Tauopathies (4RT);   Corticobasal Syndrome (CBS);   Progressive Supranuclear Palsy (PSP)
    Interventions:   Drug: TPI 287  2 mg/m2;   Drug: TPI-287 20 mg/m2;   Drug: Placebo;   Drug: TPI-287 6.3 mg/m2
    Sponsors:   University of California, San Francisco;   CBD Solutions;   Tau Consortium
    Recruiting - verified September 2014

  • Condition:   Brain Tumor
    Intervention:   Behavioral: Physical Activity
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified May 2014

  • Conditions:   Essential Tremor;   Multiple System Atrophy;   Corticobasal Degeneration;   Supranuclear Palsy, Progressive
    Intervention:  
    Sponsor:   University of Colorado, Denver
    Recruiting - verified May 2014

  • Conditions:   Neurofibromatosis Type 2;   Vestibular Schwannomas
    Intervention:   Drug: Axitinib
    Sponsor:   New York University School of Medicine
    Recruiting - verified May 2014

  • Condition:   Brain Injuries, Traumatic
    Intervention:   Device: Balance and Gait Training using neurostimulation modulation.
    Sponsor:   University of Wisconsin, Madison
    Recruiting - verified June 2014

  • Condition:   Fourth Cranial Nerve Palsy
    Intervention:   Other: teeth molding
    Sponsor:   University of Zurich
    Recruiting - verified May 2014

  • Condition:   Optic Disc Swelling
    Intervention:   Other: Retinal nerve fibre layer measurement
    Sponsors:   University of Zurich;   University Hospital, Zürich
    Recruiting - verified May 2014

  • Condition:   Progressive Supranuclear Palsy
    Interventions:   Other: MIRT and Lokomat;   Other: MIRT
    Sponsor:   Ospedale Generale Di Zona Moriggia-Pelascini
    Recruiting - verified April 2014

  • Condition:   Vestibular Neuritis
    Interventions:   Drug: Ginkgo biloba & Methylprednisolone;   Drug: Ginkgo biloba
    Sponsor:   Asan Medical Center
    Recruiting - verified March 2014

  • Condition:   Mild Traumatic Brain Injury
    Interventions:   Device: Active CN-NINM PoNS;   Device: Sham CN-NINM PoNS
    Sponsors:   U.S. Army Medical Research and Materiel Command;   Virginia Commonwealth University;   Department of Veterans Affairs;   The Defense and Veterans Brain Injury Center
    Not yet recruiting - verified October 2014

  • Condition:   Mild Traumatic Brain Injury
    Interventions:   Device: Active CN-NINM PoNS;   Device: Sham CN-NINM PoNS
    Sponsors:   U.S. Army Medical Research and Materiel Command;   Virginia Commonwealth University;   Department of Veterans Affairs;   The Defense and Veterans Brain Injury Center
    Not yet recruiting - verified October 2014

  • Condition:   Neuromyelitis Optica
    Interventions:   Drug: Alpha1-antitrypsin;   Drug: methylprednisolone
    Sponsor:   Stanford University
    Recruiting - verified March 2014

  • Condition:   Trigeminal Neuralgia
    Intervention:   Biological: Incobotulinumtoxina
    Sponsors:   Thomas Jefferson University;   Merz Pharmaceuticals, LLC
    Recruiting - verified September 2014

  • Condition:   Low Back Pain
    Interventions:   Other: CV4 Cranial (4th ventricle technique) Osteopathic Manipulative;   Other: CV4 (4th ventricle technique) manual therapy sham technique
    Sponsors:   University of Brasilia;   University Hospital of Brasília 
    Not yet recruiting - verified March 2014

  • Condition:   Neurofibromatosis Type 1
    Intervention:  
    Sponsor:   Universitaire Ziekenhuizen Leuven
    Recruiting - verified July 2014

  • Condition:   Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)
    Intervention:   Drug: SA237
    Sponsor:   Chugai Pharmaceutical
    Recruiting - verified July 2014

  • Condition:   Leber Hereditary Optic Neuropathy
    Intervention:   Genetic: GS010
    Sponsor:   GenSight Biologics
    Recruiting - verified February 2014

  • Conditions:   Alzheimer's Disease (AD);   Parkinson's Disease (PD);   Chronic Traumatic Encephalopathy (CTE);   Progressive Supranuclear Palsy (PSP);   Frontal Temporal Dementia (FTD);   Pick's Disease;   Tauopathies
    Intervention:   Drug: [18F]T807 ([18F]MNI-777)
    Sponsors:   Molecular NeuroImaging;   Institute for Neurodegenerative Disorders
    Recruiting - verified September 2014

  • Conditions:   Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Interventions:   Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
    Sponsor:   University Hospital, Bordeaux
    Recruiting - verified October 2014

  • Conditions:   Brain Disorders;   Birth Defects;   Craniofacial Differences
    Intervention:  
    Sponsors:   National Human Genome Research Institute (NHGRI);   National Eye Institute (NEI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Mount Sinai School of Medicine;   Children's Hospital Boston
    Recruiting - verified December 2013

  • Conditions:   Sporadic Acoustic Neuromas;   Useful Hearing
    Intervention:   Radiation: Radiosurgery
    Sponsor:   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
    Recruiting - verified February 2014

  • Conditions:   Non-arteritic Ischemic Optic Neuropathy;   Optic Nerve Injuries
    Interventions:   Drug: RPh201;   Drug: Placebo
    Sponsor:   Regenera Pharma Ltd
    Recruiting - verified April 2014

  • Condition:   Depressive Symptoms
    Intervention:   Device: Trigeminal Nerve Stimulation (TNS)
    Sponsors:   Santa Casa Medical School;   Faculdade de Ciências Médicas da Santa Casa de São Paulo
    Recruiting - verified May 2014

  • Conditions:   Neuromyelitis Optica (NMO);   NMO Spectrum Disorder (NMOSD)
    Intervention:   Drug: SA237
    Sponsor:   Chugai Pharmaceutical
    Recruiting - verified February 2014

  • Conditions:   Acoustic Schwannoma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Meningioma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Tumor;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Meningeal Hemangiopericytoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Medulloepithelioma;   Childhood Mixed Glioma;   Childhood Supratentorial Ependymoma;   Meningeal Melanocytoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway and Hypothalamic Glioma;   Untreated Childhood Visual Pathway Glioma
    Interventions:   Drug: fluorine F 18 fluorodopa;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: perfusion-weighted magnetic resonance imaging;   Procedure: therapeutic conventional surgery;   Procedure: biopsy;   Other: laboratory biomarker analysis
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting - verified September 2014

  • Conditions:   Non-arteritic Anterior Ischemic Optic Neuropathy;   Decreased Vision Due to Ocular Trauma
    Intervention:   Device: Transcorneal Electrical Stimulation
    Sponsor:   Wills Eye
    Recruiting - verified July 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Biological: eculizumab
    Sponsor:   Alexion Pharmaceuticals
    Not yet recruiting - verified December 2013

  • Conditions:   Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Extracranial Germ Cell Tumor;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebellar Astrocytoma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Malignant Ovarian Germ Cell Tumor;   Childhood Malignant Testicular Germ Cell Tumor;   Childhood Medulloepithelioma;   Childhood Supratentorial Ependymoma;   Childhood Teratoma;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Malignant Germ Cell Tumor;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Retinoblastoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Unspecified Childhood Solid Tumor, Protocol Specific
    Interventions:   Drug: etoposide;   Drug: ifosfamide;   Drug: carboplatin;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Drug: cyclophosphamide;   Drug: cisplatin;   Biological: filgrastim;   Other: laboratory biomarker analysis
    Sponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI);   Children's Hospital of Michigan
    Not yet recruiting - verified June 2014

  • Condition:   Optic Neuritis
    Intervention:   Drug: ACTHAR
    Sponsors:   Neuro-Ophthalmologic Associates, PC;   Questcor Pharmaceuticals, Inc.
    Recruiting - verified July 2014

  • Conditions:   Brain Metastasis;   Spinal Tumors;   Lung Tumors;   Ependymoma
    Intervention:   Radiation: SBRT treatment
    Sponsor:   Centre Leon Berard
    Recruiting - verified July 2014

  • Condition:   Parkinson's Disease
    Intervention:   Other: biweekly treatment intervention
    Sponsor:   Zia, Al Raza
    Recruiting - verified May 2014

  • Condition:   Optic Neuritis
    Interventions:   Drug: Erythropoietin alfa;   Drug: Placebo
    Sponsors:   University Eye Hospital, Freiburg;   German Federal Ministry of Education and Research;   Freunde der Universitäts-Augenklinik Freiburg e.V.
    Not yet recruiting - verified October 2014

  • Condition:   Alzheimer Disease
    Intervention:   Device: rTMS real
    Sponsor:   Lawson Health Research Institute
    Recruiting - verified March 2014

  • Condition:   Vestibular Schwannoma
    Intervention:   Radiation: Initial Gamma knife radiosurgery
    Sponsor:   Karolinska Institutet
    Recruiting - verified March 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorders
    Intervention:   Drug: Mitoxantrone
    Sponsor:   Xuanwu Hospital, Beijing
    Recruiting - verified December 2013

  • Conditions:   Retinal Disease;   Macular Degeneration;   Hereditary Retinal Dystrophy;   Optic Nerve Disease;   Glaucoma
    Interventions:   Procedure: RB (Retrobulbar);   Procedure: ST (Subtenon);   Procedure: IV (Intravenous);   Procedure: IVIT (Intravitreal);   Procedure: IO (Intraocular)
    Sponsors:   Retina Associates of South Florida;   MD Stem Cells
    Recruiting - verified November 2014

  • Condition:   Recurrent Vestibulopathy
    Interventions:   Drug: Renexin (cilostazol 100mg + gingko biloba extract 80 mg);   Drug: Placebo
    Sponsors:   Jong Woo Chung;   SK Chemicals Co.,Ltd.;   Asan Medical Center
    Recruiting - verified May 2014

  • Conditions:   Inhalational Anesthetics Adverse Reaction;   Delirium on Emergence;   Strabismus Following Ocular Surgery
    Interventions:   Drug: Dexmedetomidine;   Drug: Midazolam;   Drug: Saline
    Sponsors:   Yao Yusheng;   West China Hospital
    Recruiting - verified May 2013

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: Eculizumab
    Sponsor:   Alexion Pharmaceuticals
    Recruiting - verified November 2014

  • Condition:   Acute Autoimmune Optic Neuritis
    Interventions:   Drug: Amiloride hydrochlorothiazide;   Drug: Sugar pill
    Sponsor:   Medical University of Vienna
    Recruiting - verified May 2014

  • Conditions:   Opsoclonus Myoclonus Syndrome;   Neuroblastoma
    Interventions:   Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
    Sponsor:   Institut Curie
    Recruiting - verified October 2014

  • Condition:   Multiple Sclerosis
    Intervention:  
    Sponsors:   National Institutes of Health Clinical Center (CC);   National Institute of Neurological Disorders and Stroke (NINDS);   National Eye Institute (NEI)
    Recruiting - verified February 2014

  • Condition:   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Drug: NPB-01
    Sponsor:   Nihon Pharmaceutical Co., Ltd
    Recruiting - verified October 2014

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: ACTHAR Gel (ACTH);   Drug: IV steroids with oral taper
    Sponsors:   Elliot Frohman;   University of Colorado, Denver;   Questcor Pharmaceuticals, Inc.
    Recruiting - verified March 2014

  • Conditions:   Strabismus;   Delirium on Emergence;   Pediatric Disorders
    Interventions:   Drug: Dexmedetomidine;   Other: Placebo
    Sponsor:   New York University School of Medicine
    Recruiting - verified March 2014

  • Conditions:   Idiopathic Parkinson's Disease;   Progressive Supranuclear Palsy
    Intervention:   Device: Foot Mechanical Stimulation (GONDOLA)
    Sponsor:   IRCCS San Raffaele
    Recruiting - verified July 2014

  • Condition:   Strabismus
    Interventions:   Drug: subtenons anesthetic - preservative-free bupivacaine 0.75%;   Drug: topical anesthetic - 0.5 cc of lidocaine 3.5% ophthalmic gel;   Drug: topical control - 0.5 cc of Hypromellose 0.3% gel;   Drug: subtenons control - 0.5 cc of Normal Saline
    Sponsor:   Duke University
    Recruiting - verified May 2014

  • Conditions:   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Male Breast Cancer;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Brain Tumor;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Hypopharyngeal Cancer;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Laryngeal Cancer;   Recurrent Lip and Oral Cavity Cancer;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Nasopharyngeal Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Oropharyngeal Cancer;   Recurrent Pancreatic Cancer;   Recurrent Paranasal Sinus and Nasal Cavity Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Renal Cell Cancer;   Stage IVA Colon Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVB Colon Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVC Salivary Gland Cancer;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Radiation: fludeoxyglucose F 18;   Radiation: 2-fluoropropionyl-labeled pegylated dimeric RGD peptide;   Procedure: positron emission tomography;   Procedure: computed tomography;   Procedure: positron emission tomography;   Procedure: computed tomography;   Other: laboratory biomarker analysis
    Sponsors:   Sanjiv Sam Gambhir;   National Cancer Institute (NCI)
    Recruiting - verified October 2014

  • Condition:   Optic Atrophy
    Intervention:   Biological: STEM CELL THERAPY
    Sponsor:   Chaitanya Hospital, Pune
    Recruiting - verified September 2014

  • Condition:   Traumatic Optic Neuropathy
    Intervention:   Drug: Recombinant human erythropoietin (EPO)
    Sponsors:   Tehran University of Medical Sciences;   Iran University of Medical Sciences;   Mashhad University of Medical Sciences;   Shahid Beheshti Medical University
    Recruiting - verified March 2014

  • Conditions:   Progressive Supranuclear Palsy;   Corticobasal Degeneration
    Intervention:   Other: Observational Study
    Sponsors:   University of California, San Francisco;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
    Recruiting - verified June 2014

  • Conditions:   Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
    Intervention:  
    Sponsor:   Milton S. Hershey Medical Center
    Recruiting - verified August 2014

  • Conditions:   Neurofibromatosis Type 2;   Progressive Vestibular Schwannomas
    Intervention:   Drug: Bevacizumab
    Sponsors:   University of Alabama at Birmingham;   Genentech, Inc.
    Recruiting - verified May 2013

  • Conditions:   Amblyopia ex Strabismus;   Amblyopia ex Anisometropia
    Interventions:   Device: Dynamic Vessel Analyzer;   Other: Laser Doppler Velocimetry;   Device: 7-Tesla MRI;   Other: Pattern electroretinography
    Sponsor:   Medical University of Vienna
    Recruiting - verified November 2014

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: Verum arm receiving Gilenya®;   Drug: Active Comparator receiving Extavia®
    Sponsors:   Charite University, Berlin, Germany;   Charité Neurocure AG Flöel
    Recruiting - verified September 2014

  • Conditions:   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Mixed Glioma;   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Adult Pineal Gland Astrocytoma;   AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Primary CNS Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Anaplastic Thyroid Cancer;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extensive Stage Small Cell Lung Cancer;   Extra-adrenal Paraganglioma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Gastrinoma;   Glucagonoma;   Hepatic Complications;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Insular Thyroid Cancer;   Insulinoma;   Intraocular Lymphoma;   Male Breast Cancer;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Pheochromocytoma;   Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Pancreatic Polypeptide Tumor;   Peripheral T-cell Lymphoma;   Pulmonary Carcinoid Tumor;   Recurrent Adenoid Cystic Carcinoma of the Oral Cavity;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Brain Tumor;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Basal Cell Carcinoma of the Lip;   Recurrent Bladder Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Islet Cell Carcinoma;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Lymphoepithelioma of the Oropharynx;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Melanoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Recurrent Mucoepidermoid Carcinoma of the Oral Cavity;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Neuroendocrine Carcinoma of the Skin;   Recurrent Non-small Cell Lung Cancer;   Recurrent Pancreatic Cancer;   Recurrent Pheochromocytoma;   Recurrent Prostate Cancer;   Recurrent Rectal Cancer;   Recurrent Renal Cell Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Small Lymphocytic Lymphoma;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Thyroid Cancer;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Regional Gastrointestinal Carcinoid Tumor;   Regional Pheochromocytoma;   Small Intestine Lymphoma;   Somatostatinoma;   Splenic Marginal Zone Lymphoma;   Stage III Adenoid Cystic Carcinoma of the Oral Cavity;   Stage III Adult Soft Tissue Sarcoma;   Stage III Basal Cell Carcinoma of the Lip;   Stage III Bladder Cancer;   Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage III Follicular Thyroid Cancer;   Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Lymphoepithelioma of the Oropharynx;   Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage III Mucoepidermoid Carcinoma of the Oral Cavity;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage III Pancreatic Cancer;   Stage III Papillary Thyroid Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage III Salivary Gland Cancer;   Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IIIA Breast Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Melanoma;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Melanoma;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Breast Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Melanoma;   Stage IIIC Rectal Cancer;   Stage IV Adult Soft Tissue Sarcoma;   Stage IV Bladder Cancer;   Stage IV Breast Cancer;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Melanoma;   Stage IV Neuroendocrine Carcinoma of the Skin;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVA Basal Cell Carcinoma of the Lip;   Stage IVA Colon Cancer;   Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Follicular Thyroid Cancer;   Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Lymphoepithelioma of the Oropharynx;   Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVA Papillary Thyroid Cancer;   Stage IVA Rectal Cancer;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVB Basal Cell Carcinoma of the Lip;   Stage IVB Colon Cancer;   Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Follicular Thyroid Cancer;   Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Lymphoepithelioma of the Oropharynx;   Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVB Papillary Thyroid Cancer;   Stage IVB Rectal Cancer;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity;   Stage IVC Basal Cell Carcinoma of the Lip;   Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Follicular Thyroid Cancer;   Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Lymphoepithelioma of the Oropharynx;   Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity;   Stage IVC Papillary Thyroid Cancer;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   T-cell Large Granular Lymphocyte Leukemia;   Testicular Lymphoma;   Thyroid Gland Medullary Carcinoma;   Tongue Cancer;   Unspecified Adult Solid Tumor, Protocol Specific;   Waldenström Macroglobulinemia
    Interventions:   Drug: romidepsin;   Other: pharmacological study
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified August 2014

  • Condition:   Facial Bones Fracture
    Intervention:   Drug: Ramosetron
    Sponsor:   Seoul National University Hospital
    Recruiting - verified November 2014

  • Conditions:   Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
    Intervention:  
    Sponsor:   University of Alabama at Birmingham
    Recruiting - verified July 2014

  • Condition:   Convergence Insufficiency
    Interventions:   Other: Active home-based computer vergence/accommodative therapy;   Procedure: Near target push-ups;   Other: Placebo home-based computer vergence/accommodative therapy;   Procedure: Placebo yoked prism flippers
    Sponsors:   Jaeb Center for Health Research;   National Eye Institute (NEI)
    Recruiting - verified June 2014

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Recurrent Idiopathic Longitudinally Extensive Transverse Myelitis
    Intervention:   Procedure: Plasma exchange (PLEX)
    Sponsors:   Mayo Clinic;   Terumo BCT
    Recruiting - verified January 2014

  • Conditions:   Optic Neuritis;   Multiple Sclerosis
    Interventions:   Drug: Phenytoin;   Drug: Placebo
    Sponsors:   University College, London;   National Multiple Sclerosis Society;   Multiple Sclerosis Society of Great Britain and Northern Ireland
    Recruiting - verified December 2013

  • Conditions:   Muscular Dystrophy;   Congenital Muscular Dystrophy;   Fukutin-related Protein Gene;   Limb Girdle;   FKRP Gene;   Childhood Onset LGMD;   Adult Onset LGMD;   POMT1;   POMT2;   POMGnT1;   LARGE;   Alpha Dystroglycan;   Dystroglycanopathy;   Centronuclear;   Multiminicore;   Multicore;   Minicore;   Congenital Fiber Type Disproportion;   Myotubular;   Nemaline;   Congenital Myopathy;   Neuromuscular;   Rigid Spine;   Phenotype-Genotype Correlation;   Cough Assisted Device;   Neuromuscular Disease;   Respiratory Exacerbation;   Invasive Ventilation;   Chest Physiotherapy;   Congenital Myopathies;   Genetic Mutations;   Hypertrophic Cardiomyopathy;   Wheelchair Use;   Cataract;   Opthalmoplegia;   Ullrich Congenital Muscular Dystrophy;   Intermediate Collagen VI Myopathy;   Laminin Alpha 2 Related Congenital Muscular Dystrophy;   MDC1A;   Merosin Deficient Congenital Muscular Dystrophy;   Congenital Muscular Dystrophy Undiagnosed;   Congenital Muscular Dystrophy Merosin Positive;   Walker Warburg Syndrome;   Muscle Eye Brain Disease;   Fukuyama;   Integrin Alpha 7 Deficiency;   Integrin Alpha 9 Deficiency;   Laminopathy;   Lamin AC;   SEPN 1 Related Myopathies;   Bethlem Myopathy;   Dystroglycanopathies;   LGMD2K;   LGMD2I;   LGMD2L;   LGMD2N;   Actin Aggregation Myopathy;   Cap Disease;   Central Core Disease;   Centronuclear Myopathy;   Core Rod Myopathy;   Hyaline Body Myopathy;   Multiminicore Myopathy;   Myotubular Myopathy;   Nemaline Myopathy;   Tubular Aggregate Myopathy;   Zebra Body Disease Myopathy;   Congenital Myopathy Other;   Reducing Body Myopathy;   Sarcotubular Myopathy;   Spheroid Body Myopathy
    Intervention:  
    Sponsor:   Cure CMD
    Recruiting - verified June 2014

  • Conditions:   Optic Glioma;   Pilocytic Astrocytoma;   Low Grade Glioma;   Fibriullary Astrocytoma
    Intervention:   Drug: AZD6244
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified October 2014

  • Condition:   Brain Injury
    Intervention:   Drug: 1: Sevoflurane
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Ministry of Health, France
    Recruiting - verified June 2014

  • Conditions:   Retinal Diseases;   Optic Nerve Diseases
    Interventions:   Other: Observational: to better characterize the retina and optic nerve in newborns using spectral domain optical coherence tomography (s-oct).;   Procedure: OCT imaging.
    Sponsors:   University of California, Los Angeles;   Los Angeles Biomedical Research Institute
    Recruiting - verified December 2013

  • Conditions:   Multiple Sclerosis;   Optic Neuritis
    Intervention:   Drug: Mangafodipir (Teslascan)
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified July 2014

  • Condition:   Intermittent Exotropia
    Intervention:   Procedure: Non surgical therapy
    Sponsor:   Singapore National Eye Centre
    Recruiting - verified November 2014

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma
    Intervention:   Radiation: Fractionated proton radiation
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting - verified October 2014

  • Condition:   Bell's Palsy
    Interventions:   Drug: Prednisolone;   Device: acupuncture;   Other: other treatment
    Sponsor:   Xijing Hospital
    Recruiting - verified August 2014

  • Condition:   Esotropia
    Interventions:   Procedure: mVEP Testing;   Procedure: Stereoacuity Testing;   Procedure: Optokinetic nystagmus testing;   Procedure: Motion detection testing;   Procedure: Motion discrimination testing
    Sponsor:   The Hospital for Sick Children
    Recruiting - verified November 2014

  • Condition:   Nonarteritic Anterior Ischemic Optic Neuropathy
    Intervention:   Drug: PDE5 Inhibitors
    Sponsor:   Eli Lilly and Company
    Recruiting - verified June 2014

  • Conditions:   Childhood Low-grade Cerebellar Astrocytoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Mixed Glioma;   Childhood Pilocytic Astrocytoma;   Neurofibromatosis Type 1;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma
    Interventions:   Drug: selumetinib;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified October 2014

  • Conditions:   Neurofibromatosis Type 1;   Malignant Peripheral Nerve Sheath Tumor;   Plexiform Neurofibroma;   Optic Glioma;   Neurofibroma
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified April 2014

  • Conditions:   Childhood Atypical Teratoid/Rhabdoid Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Choroid Plexus Tumor;   Childhood Craniopharyngioma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood High-grade Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Low-grade Cerebral Astrocytoma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway and Hypothalamic Glioma;   Recurrent Childhood Visual Pathway Glioma
    Intervention:   Other: cytology specimen collection procedure
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified August 2014

  • Condition:   Anterior Ischemic Optic Neuropathy
    Intervention:   Drug: Diagnostic procedures
    Sponsor:   Bayer
    Recruiting - verified October 2014

  • Condition:   Opsoclonus-myoclonus Syndrome
    Intervention:  
    Sponsor:   National Pediatric Myoclonus Center
    Recruiting - verified January 2014

  • Condition:   Devic's Disease
    Intervention:   Procedure: Hematopoietic stem cell transplantation
    Sponsor:   Northwestern University
    Recruiting - verified September 2014

  • Conditions:   Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting - verified January 2014


PaidClinicalTrials.orgPaidClinicalTrials.org